Cargando…
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
Drug repurposing provides a rapid approach to meet the urgent need for therapeutics to address COVID-19. To identify therapeutic targets relevant to COVID-19, we conducted Mendelian randomization (MR) analyses, deriving genetic instruments based on transcriptomic and proteomic data for 1,263 actiona...
Ejemplares similares
-
Pharmacogenetic allele variant frequencies: An analysis of the VA’s Million Veteran Program (MVP) as a representation of the diversity in US population
por: Markianos, Kyriacos, et al.
Publicado: (2023) -
Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program
por: Song, Rebecca J., et al.
Publicado: (2021) -
Baseline Characterization and Annual Trends of Body Mass Index for a Mega-Biobank Cohort of US Veterans 2011–2017
por: Nguyen, Xuan-Mai T., et al.
Publicado: (2018) -
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program
por: Serper, Marina, et al.
Publicado: (2020) -
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure
por: Rasooly, Danielle, et al.
Publicado: (2023)